Cargando…
Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361492/ https://www.ncbi.nlm.nih.gov/pubmed/25505051 http://dx.doi.org/10.1177/0272989X14563081 |
| _version_ | 1782361640902066176 |
|---|---|
| author | Johnson, Scott J. Davis, Matthew R. Wang, Si-Tien |
| author_facet | Johnson, Scott J. Davis, Matthew R. Wang, Si-Tien |
| author_sort | Johnson, Scott J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4361492 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43614922015-04-10 Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease Johnson, Scott J. Davis, Matthew R. Wang, Si-Tien Med Decis Making Letters to the Editor SAGE Publications 2015-02 /pmc/articles/PMC4361492/ /pubmed/25505051 http://dx.doi.org/10.1177/0272989X14563081 Text en © The Author(s) 2014 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm). |
| spellingShingle | Letters to the Editor Johnson, Scott J. Davis, Matthew R. Wang, Si-Tien Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease |
| title | Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease |
| title_full | Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease |
| title_fullStr | Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease |
| title_full_unstemmed | Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease |
| title_short | Importance of Transparency in Assessing the Feasibility of Modeling Rare Disease |
| title_sort | importance of transparency in assessing the feasibility of modeling rare disease |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361492/ https://www.ncbi.nlm.nih.gov/pubmed/25505051 http://dx.doi.org/10.1177/0272989X14563081 |
| work_keys_str_mv | AT johnsonscottj importanceoftransparencyinassessingthefeasibilityofmodelingraredisease AT davismatthewr importanceoftransparencyinassessingthefeasibilityofmodelingraredisease AT wangsitien importanceoftransparencyinassessingthefeasibilityofmodelingraredisease |